Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1988 Jan;43(1):19–23. doi: 10.1136/thx.43.1.19

Subcutaneous adrenaline versus terbutaline in the treatment of acute severe asthma.

M A Spiteri 1, A B Millar 1, D Pavia 1, S W Clarke 1
PMCID: PMC461081  PMID: 3281307

Abstract

Subcutaneous adrenaline and terbutaline have been compared in a double blind study of 20 patients with acute severe asthma presenting to an accident and emergency department. Ten patients received adrenaline 0.5 mg (0.5 ml) and 10 terbutaline 0.5 mg (0.5 ml) subcutaneously. Further treatment with nebulised salbutamol (5 mg), hydrocortisone (200 mg), and aminophylline (0.9 mg/kg/hour) was started 15 minutes later. All patients reported a reduction in chest tightness within three minutes of receiving both adrenaline and terbutaline and reported no adverse effects. Mean baseline values of peak expiratory flow (PEF) and forced expiratory volume in one second (FEV1) did not differ significantly between the adrenaline group (130 1 min-1 and 0.83 l) and the terbutaline group (111 1 min-1 and 0.63 l). After administration of adrenaline PEF had increased by 21% and FEV1 by 40% five minutes after the injection, and by 35% and 64% at 15 minutes. Terbutaline caused a 23% increase in PEF and a 37% increase in FEV1 at five minutes, and a 40% and 58% increase at 15 minutes. There was no significant difference in PEF, FEV1, heart rate, blood pressure, or pulsus paradoxus between the two groups at any time. Continuous electrocardiographic recording showed no abnormalities in either group. Thus in this study subcutaneous adrenaline (0.5 mg) and terbutaline (0.5 mg) produced effective rapid bronchodilatation without serious side effects.

Full text

PDF
19

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arner B., Bertler A., Karlefors T., Westling H. Circulatory effects of orciprenaline, adrenaline and a new sympathomimetic beta-receptor-stimulating agent, terbutaline, in normal human subjects. Acta Med Scand Suppl. 1970;512:25–32. doi: 10.1111/j.0954-6820.1970.tb05286.x. [DOI] [PubMed] [Google Scholar]
  2. BENDKOWSKI B. EFFECTS OF ADRENALINE INJECTIONS ON ECG IN ELDERLY ASTHMATICS. J Coll Gen Pract. 1964 Jul;8:66–71. [PMC free article] [PubMed] [Google Scholar]
  3. Barger G., Dale H. H. Chemical structure and sympathomimetic action of amines. J Physiol. 1910 Oct 11;41(1-2):19–59. doi: 10.1113/jphysiol.1910.sp001392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bateman J. R., Clarke S. W. Sudden death in asthma. Thorax. 1979 Feb;34(1):40–44. doi: 10.1136/thx.34.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Baughman R. P., Ploysongsang Y., James W. A comparative study of aerosolized terbutaline and subcutaneously administered epinephrine in the treatment of acute bronchial asthma. Ann Allergy. 1984 Aug;53(2):131–134. [PubMed] [Google Scholar]
  6. Ben-Zvi Z., Lam C., Spohn W. A., Gribetz I., Mulvihill M. N., Kattan M. An evaluation of repeated injections of epinephrine for the initial treatment of acute asthma. Am Rev Respir Dis. 1983 Jan;127(1):101–105. doi: 10.1164/arrd.1983.127.1.101. [DOI] [PubMed] [Google Scholar]
  7. Cochrane G. M., Clark J. H. A survey of asthma mortality in patients between ages 35 and 64 in the Greater London hospitals in 1971. Thorax. 1975 Jun;30(3):300–305. doi: 10.1136/thx.30.3.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crompton G. K. Special problems of clinical trials in status asthmaticus [proceedings]. Br J Dis Chest. 1977 Oct;71(4):242–244. [PubMed] [Google Scholar]
  9. FREEDMAN B. J. Accidental adrenaline overdosage and its treatment with piperoxan. Lancet. 1955 Sep 17;269(6890):575–578. doi: 10.1016/s0140-6736(55)92581-2. [DOI] [PubMed] [Google Scholar]
  10. Gotz V. P., Brandstetter R. D., Mar D. D. Bronchodilatory effect of subcutaneous epinephrine in acute asthma. Ann Emerg Med. 1981 Oct;10(10):518–520. doi: 10.1016/s0196-0644(81)80006-6. [DOI] [PubMed] [Google Scholar]
  11. Hetzel M. R., Clark T. J., Branthwaite M. A. Asthma: analysis of sudden deaths and ventilatory arrests in hospital. Br Med J. 1977 Mar 26;1(6064):808–811. doi: 10.1136/bmj.1.6064.808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johansen S. Clinical comparison of intramuscular terbutaline and subcutaneous adrenaline in bronchial asthma. Eur J Clin Pharmacol. 1974;7(3):163–167. doi: 10.1007/BF00560376. [DOI] [PubMed] [Google Scholar]
  13. Karetzky M. S. Acute asthma: the use of subcutaneous epinephrine in therapy. Ann Allergy. 1980 Jan;44(1):12–14. [PubMed] [Google Scholar]
  14. Med M. Prenatal development of lumbar intervertebral articulation. Folia Morphol (Praha) 1982;30(3):285–290. [PubMed] [Google Scholar]
  15. Paterson J. W., Woolcock A. J., Shenfield G. M. Bronchodilator drugs. Am Rev Respir Dis. 1979 Nov;120(5):1149–1188. doi: 10.1164/arrd.1979.120.5.1149. [DOI] [PubMed] [Google Scholar]
  16. Rossing T. H., Fanta C. H., Goldstein D. H., Snapper J. R., McFadden E. R., Jr Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis. 1980 Sep;122(3):365–371. doi: 10.1164/arrd.1980.122.3.365. [DOI] [PubMed] [Google Scholar]
  17. Rossing T. H., Fanta C. H., McFadden E. R., Jr A controlled trial of the use of single versus combined-drug therapy in the treatment of acute episodes of asthma. Am Rev Respir Dis. 1981 Feb;123(2):190–194. doi: 10.1164/arrd.1981.123.2.190. [DOI] [PubMed] [Google Scholar]
  18. Smith P. R., Heurich A. E., Leffler C. T., Henis M. M., Lyons H. A. A comparative study of subcutaneously administered terbutaline and epinephrine in the treatment of acute bronchial asthma. Chest. 1977 Feb;71(2):129–134. doi: 10.1378/chest.71.2.129. [DOI] [PubMed] [Google Scholar]
  19. Stableforth D. Death from asthma. Thorax. 1983 Nov;38(11):801–805. doi: 10.1136/thx.38.11.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tinkelman D. G., Vanderpool G. E., Carroll M. S., Lotner G. Z., Spangler D. L. Comparison of nebulized terbutaline (TERB) and subcutaneous epinephrine (EPI) in the treatment of acute asthma. Ann Allergy. 1983 Jun;50(6):398–401. [PubMed] [Google Scholar]
  21. van den Berg W., Leferink J. G., Maes R. A., Fokkens J. K., Kreukniet J., Bruynzeel P. L. The effects of oral and subcutaneous administration of terbutaline in asthmatic patients. Eur J Respir Dis Suppl. 1984;134:181–193. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES